Korean J Hepatobiliary Pancreat Surg.  2002 Dec;6(2):195-199.

Chemoembolization in Synchronous Liver Metastases from Nonfunctioning Endocrine Tumor of Pancreas

Affiliations
  • 1Department of Surgery, Sanggye Paik Hospital, Inje University, Seoul, Korea. ileus@freechal.com
  • 2Department of Diagnostic Pathology, Sanggye Paik Hospital, Inje University, Seoul, Korea.

Abstract

Pancreatic endocrine tumors are rare and represent a heterogeneous group of benign or malignant lesions. In nonfunctioning tumors, lacking the features of an endocrine tumor syndrome, they seldom present until there is advanced local disease. Endocrine tumors of the pancreas, even in case of liver involvement, are generally characterized by a slower evolution and a better prognosis, if compared with ductal carcinoma. This fact gives reason to a radical surgical approach and to the research of any effective adjuvant treatment including hormonal suppression, systemic chemotherapy and hepatic transarterial chemoembolization (TACE). We report a case of synchronous liver metastases from nonfunctioning pancreatic endocrine tumor in 66 year old female patient.

Keyword

Pancreatic endocrine tumor; Nonfunctioning; Chemoembolization

MeSH Terms

Aged
Carcinoma, Ductal
Drug Therapy
Female
Humans
Liver*
Neoplasm Metastasis*
Pancreas*
Prognosis
Full Text Links
  • KJHBPS
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr